Upgrade to SI Premium - Free Trial

LNAI (LNAI)

2.30 +0.01 (0.44%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Lunai Bioworks partners with BrainStorm for neurology drug discovery May 28, 2026 9:16 AM - StreetInsider Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration May 28, 2026 9:15 AM - PR NewsWire Federal judge grants Lunai expedited discovery in naked short selling case May 22, 2026 9:15 AM - StreetInsider Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock May 22, 2026 9:15 AM - PR NewsWire Form 8-K Lunai Bioworks Inc. For: May 20 May 20, 2026 9:15 AM - SEC Filing Lunai Bioworks announces 1-for-8 reverse stock split effective May 22 May 20, 2026 9:15 AM - StreetInsider LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT May 20, 2026 9:15 AM - PR NewsWire Form 10-Q Lunai Bioworks Inc. For: Mar 31 May 15, 2026 4:46 PM - SEC Filing LNAI stockholders approve reverse stock split proposal May 13, 2026 4:53 PM - StreetInsider Form 8-K Lunai Bioworks Inc. For: May 08 May 13, 2026 4:46 PM - SEC Filing CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research May 13, 2026 8:30 AM - Globe NewsWire Dickinson Wright and Fox Rothschild Join Forces to File Lawsuit Against ‘John Doe’ ‘Naked’ Short-Sellers of Lunai Common Stock May 12, 2026 12:13 AM - StreetInsider Form 8-K/A Lunai Bioworks Inc. For: Apr 27 May 11, 2026 5:31 PM - SEC Filing Lunai Bioworks raises $20M to acquire CNS delivery technology May 4, 2026 9:35 AM - StreetInsider Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP May 4, 2026 9:35 AM - PR NewsWire Form DEFR14A Lunai Bioworks Inc. May 1, 2026 5:19 PM - SEC Filing Form 8-K Lunai Bioworks Inc. For: Apr 27 May 1, 2026 5:17 PM - SEC Filing Form 8-K Lunai Bioworks Inc. For: Apr 27 April 28, 2026 5:30 PM - SEC Filing Form DEFA14A Lunai Bioworks Inc. April 28, 2026 5:01 PM - SEC Filing Lunai Bioworks signs letter of intent with Geneial for rare disease data April 15, 2026 9:10 AM - StreetInsider Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships April 15, 2026 9:10 AM - PR NewsWire Form DEFR14A Lunai Bioworks Inc. April 15, 2026 6:12 AM - SEC Filing Form DEF 14A Lunai Bioworks Inc. For: Apr 13 April 13, 2026 5:16 PM - SEC Filing Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion April 7, 2026 1:06 PM - PR NewsWire Lunai Bioworks subsidiary lands defense contract for AI threat platform April 7, 2026 9:09 AM - StreetInsider Form PRE 14A Lunai Bioworks Inc. For: Apr 02 April 2, 2026 5:02 PM - SEC Filing Form 8-K Lunai Bioworks Inc. For: Mar 24 March 30, 2026 5:43 PM - SEC Filing Lunai Bioworks acquires brain delivery tech in $20M deal March 26, 2026 8:51 AM - StreetInsider Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications March 26, 2026 8:51 AM - PR NewsWire Lunai Bioworks forms chemical defense consortium targeting federal programs March 19, 2026 9:59 AM - StreetInsider Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model March 19, 2026 9:58 AM - PR NewsWire Full Article List